CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2020; 07(02): 091-095
DOI: 10.1055/s-0039-1697558
Brief Report

Randomized Controlled Trial of Intravenous Dexmedetomidine for Control of Hemodynamics, Surgical Bleeding, and Recovery Profile during Transsphenoidal Pituitary Surgery

Preethy J. Mathew
1   Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research, Chandigarh, India
,
Aparna Jain
1   Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research, Chandigarh, India
,
Jyotsna Wig
1   Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research, Chandigarh, India
,
Kanchan K. Mukherjee
2   Department of Neurosurgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India
,
Aakriti Gupta
1   Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research, Chandigarh, India
› Author Affiliations

Abstract

Background Microscopic transsphenoidal excision of pituitary gland, though considered safe from neurosurgical point of view, produces marked cardiovascular and stress responses despite adequate depth of anesthesia. The aim of this study was to evaluate the effect of dexmedetomidine bolus and infusion in microscopic transsphenoidal pituitary surgery on hemodynamics, bleeding in surgical field, and recovery parameters.

Materials and Methods A prospective randomized double-blind study was conducted in 40 American Society of Anesthesiologists (ASA) I-II patients between 18 and 65 years, who underwent elective transsphenoidal excision of pituitary tumor. Two groups were constituted: one group received dexmedetomidine 1 μg/kg loading dose followed by 0.5 μg/kg/h infusion, the other received placebo bolus and infusion. A standard anesthesia protocol including isoflurane and fentanyl was used in both groups. The hemodynamic profile, intraoperative bleeding, and recovery profile were studied.

Results The heart rate (HR) did not vary significantly from the baseline during surgery and recovery in the dexmedetomidine group. The systolic, diastolic, and mean blood pressures decreased significantly with dexmedetomidine in statistical terms, though they were within the clinically acceptable range and did not require intervention. On comparing the groups, dexmedetomidine group had better perioperative blood pressure profile and decreased isoflurane requirement. Bleeding scores during surgery and recovery were similar in both groups.

Conclusions Intraoperative use of dexmedetomidine in transsphenoidal pituitary surgery provided stable perioperative hemodynamics comprising reduced cardiovascular response to intubation and surgical noxious stimuli along with a similar recovery compared with the control group. Therefore, dexmedetomidine appears as a useful adjunct to control hemodynamics in neurosurgical patients undergoing transsphenoidal surgery.



Publication History

Article published online:
21 October 2019

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Abou-Madi MN, Trop D, Barnes J. Aetiology and control of cardiovascular reactions during trans-sphenoidal resection of pituitary microadenomas. Can Anaesth Soc J 1980; 27 (05) 491-495
  • 2 Messick Jr. JM, Laws Jr. ER, Abboud CF. Anesthesia for transsphenoidal surgery of the hypophyseal region. Anesth Analg 1978; 57 (02) 206-215
  • 3 Muralidhar K, Bhanumurthy S. Attenuation of the cardiovascular responses to subcutaneous adrenaline in neurosurgical patients. Br J Anaesth 1992; 68 (03) 264-267
  • 4 Durmus M, But AK, Dogan Z, Yucel A, Miman MC, Ersoy MO. Effect of dexmedetomidine on bleeding during tympanoplasty or septorhinoplasty. Eur J Anaesthesiol 2007; 24 (05) 447-453
  • 5 Ayoglu H, Yapakci O, Ugur MB. et al. Effectiveness of dexmedetomidine in reducing bleeding during septoplasty and tympanoplasty operations. J Clin Anesth 2008; 20 (06) 437-441
  • 6 Gopalakrishna KN, Dash PK, Chatterjee N, Easwer HV, Ganesamoorthi A. Dexmedetomidine as an anaesthetic adjuvant in patients undergoing transsphenoidal resection of pituitary tumour. J Neurosurg Anesthesiol 2015; 27 (03) 209-215
  • 7 Salimi A, Sharifi G, Bahrani H. et al. Dexmedetomidine could enhance surgical satisfaction in trans-sphenoidal resection of pituitary adenoma. J Neurosurg Sci 2017; 61 (01) 46-52
  • 8 Aldrete JA. The post-anesthesia recovery score revisited. J Clin Anesth 1995; 7 (01) 89-91
  • 9 Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. BMJ 1974; 2 (5920) 656-659
  • 10 Kunisawa T, Nagata O, Nagashima M. et al. Dexmedetomidine suppresses the decrease in blood pressure during anesthetic induction and blunts the cardiovascular response to tracheal intubation. J Clin Anesth 2009; 21 (03) 194-199
  • 11 Lawrence CJ, Prinzen FW, de Lange S. The effect of dexmedetomidine on the balance of myocardial energy requirement and oxygen supply and demand. Anesth Analg 1996; 82 (03) 544-550
  • 12 Fragen RJ, Fitzgerald PC. Effect of dexmedetomidine on the minimum alveolar concentration (MAC) of sevoflurane in adults age 55 to 70  years. J Clin Anesth 1999; 11 (06) 466-470
  • 13 Aantaa R, Kanto J, Scheinin M, Kallio A, Scheinin H. Dexmedetomidine,an. α 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. Anesthesiology 1990; 73 (02) 230-235
  • 14 Kamibayashi T, Maze M. Clinical uses of alpha2-adrenergic agonists. Anesthesiology 2000; 93 (05) 1345-1349
  • 15 Turgut N, Turkmen A, Gökkaya S, Altan A, Hatiboglu MA. Dexmedetomidine-based versus fentanyl-based total intravenous anesthesia for lumbar laminectomy. Minerva Anestesiol 2008; 74 (09) 469-474
  • 16 Kim SY, Kim JM, Lee JH, Song BM, Koo BN. Efficacy of intraoperative dexmedetomidine infusion on emergence agitation and quality of recovery after nasal surgery. Br J Anaesth 2013; 111 (02) 222-228